Invasive aspergillosis in the ICU: An emerging disease

Intensive Care Medicine

Volumn 33, Issue 10, 2007, Pages 1679-1681

  Meersseman, Wouter ^a   Van Wijngaerden, Eric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; GLUCONIC ACID; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ASPERGILLOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; INTENSIVE CARE UNIT; LUNG ALVEOLUS MACROPHAGE; MICROBIOLOGY; NEUTROPENIA; POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY ANALYSIS;

ANTIFUNGAL AGENTS; ASPERGILLUS; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; LUNG DISEASES, FUNGAL; OPPORTUNISTIC INFECTIONS;

EID: 34748906546     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0792-y     Document Type: Editorial

References (17)

1. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes ARJ, Groeneveld ABJ (2007) Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med (DOI 10.1007/s00134-007-0791-z )
2. Segal BH, Walsh TJ (2006) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173:707-717
3. Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366:1013-1025
4. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically III patients without malignancy. Am J Respir Crit Care Med 170:621-625
5. Vandewoude KH, Blot S, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31
6. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena J, Barcenilla F (2005) Isolation of Aspergillus spp from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9:R191-R199
7. Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH (2003) Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29:2068-2071
8. Vandewoude KH, Vogelaers D (2007) Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis 44:380-381
9. Perfect JR, Cox GM, Lee JY Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA, Mycoses Study Group (2001) The impact of culture isolation of aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824-1833
10. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882-885
11. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener M, Singh N (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 42:435-438
12. Husain S, Kwak EJ, Obman A, Wagener M, Kusne S, Stout J, McCurry K, Singh N (2004) Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transpl 4:796-802
13. Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83:1330-1336
14. Sulahian A, Touratier S, Ribaud P (2003) False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349:2366-2377
15. Surmont I, Stockman W (2007) Gluconate-containing solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 45:1373
16. Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142-1151
17. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer, The Global Aspergillus Study Group (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415